On August 14, Lindsay Bealor Greenleaf, Vice President and Solution Leader, Federal and State Policy at ADVI Health, spoke with Axios on her predictions for the announcement of the Inflation Reduction Act’s (IRA) first drug price negotiations.

In the article, “What to watch when Medicare releases first negotiated drug prices,” Lindsay shared her thoughts on pharmacy benefit middlemen and how they might react to these new drug prices, saying that it could potentially lead them to give competing products more favorable placement on their formularies.

Read more insights on Axios.